Goldline Pharmaceutical IPO IPO GMP
Grey Market PremiumLast Updated: 12 May 2026, 02:41 pm
Current GMP
₹18
+41.86%
Issue Price
₹43
₹41 – ₹43
Expected Listing
₹61
Based on current GMP
Kostak Rate
N/A
Per application premium
Subject to Sauda
Per lot premium (contingent on allotment)
₹54000
Disclaimer
Grey Market Premium (GMP) is unofficial and not regulated by SEBI. It reflects grey market sentiment only and should not be the sole basis for investment decisions. GMP can change rapidly and may not reflect the actual listing price.
Goldline Pharmaceutical IPO GMP History
Grey market premium trend over the last 30 days
| Date | GMP (₹) | GMP % | Est. Listing | Kostak | Trend | Updated At (IST) |
|---|---|---|---|---|---|---|
| 12 May 2026 | ₹18 | +41.86% | ₹61 | – | 12 May 2026, 02:41 pm | |
| 11 May 2026 | ₹15 | +34.88% | ₹58 | – | 11 May 2026, 02:41 pm | |
| 7 May 2026 | ₹13 | +30.23% | ₹56 | – | 7 May 2026, 02:41 pm |
What is Goldline Pharmaceutical IPO GMP (Grey Market Premium)?
Goldline Pharmaceutical IPO GMP (Grey Market Premium) is the premium at which shares of Goldline Pharmaceutical IPO IPO are being traded in the unofficial grey market before the official listing on stock exchanges. Currently, the GMP for Goldline Pharmaceutical IPO IPO is ₹18 (41.86%), indicating an expected listing price of ₹61.
Grey Market Premium (GMP)
The premium over issue price at which IPO shares trade in the grey market. If issue price is ₹100 and GMP is ₹50, grey market price is ₹150.
Kostak Rate
The premium for selling your IPO application before allotment. You receive this amount per lot regardless of whether you get allotment.
Subject to Sauda
Premium per lot to buy an allotment in the grey market before listing. The deal is cancelled if the buyer does not receive allotment.
Expected Listing Price
Issue Price + Current GMP. This is an estimate only — actual listing price may differ significantly from the expected price.
Goldline Pharmaceutical IPO GMP — Frequently Asked Questions
What is Goldline Pharmaceutical IPO GMP today?
Goldline Pharmaceutical IPO GMP today is ₹18 (41.86%). The expected listing price based on current GMP is ₹61.
What is the expected listing price of Goldline Pharmaceutical IPO IPO?
Based on current GMP of ₹18, the expected listing price of Goldline Pharmaceutical IPO IPO is approximately ₹61 (issue price ₹43 + GMP ₹18).
Is GMP a reliable indicator for IPO listing?
GMP can give a rough indication of market sentiment, but it is unofficial and unregulated by SEBI. Actual listing price can be significantly higher or lower than what GMP suggests. Always do thorough research before investing.
What is the Kostak rate for Goldline Pharmaceutical IPO IPO?
Kostak rate for Goldline Pharmaceutical IPO IPO is not yet available. Check back for updates.
GMP Discussion
Share live GMP updates, kostak rates, or ask about listing expectations
Be the first to ask or share about Goldline Pharmaceutical IPO